目的探讨1型糖尿病(T1DM)患者中蛋白酪氨酸磷酸酶2B抗体(IA-2βA)的分布规律及阳性患者的临床特征。方法采用放射配体法检测401例T1DM患者、200例正常对照血清中IA-2βA、IA-2A和谷氨酸脱羧酶抗体(GADA)水平,并分析抗体阳性患者的临床特征。结果(1)T1DM组IA-2βA阳性率8.7%(35/401),显著高于正常对照组(1.0%,P〈0.05);(2)35例IA-2βA阳性患者中,同时合并IA-2A阳性的患者16例,阳性重叠率45.7%。IA-2BA与IA-2A指数无相关性(r=0.021,P=0.780);(3)T1DM患者中,IA-2A、IA-2βA阳性率在0~9岁组最高,二者阳性率显著高于10岁以上的T1DM患者(62.8%vs 19.7%,Χ^2=31.41,P〈0.001;20.0%vs 7.6%,Χ^2=6.11,P〈0.05)。而GADA阳性率在各年龄组中差异无统计学意义;(4)与单独IA-2A阳性患者比较。单独IA-2βA阳性患者年龄和起病年龄较大(IA-2A阳性患者平均年龄24.2岁,平均起病年龄21.6岁;IA-2βA阳性患者平均年龄35.5岁,平均起病年龄34.0岁,均P〈0.05)。结论IA-2βA在儿童T1DM患者中阳性率较高,且随年龄增长阳性率下降。IA-2βA是糖尿病患者自身免疫检测的一项实用指标。
Objective To explore the prevalence and clinical features of protein tyrosine phosphatase-2β antibody (IA-2βA) in type 1 diabetes(T1DM). Methods Four hundred and one T1DM patients and 200 healthy controls were screened for glutamic acid carboxylase antibody ( GADA), islet cell antigen-2 (IA-2A), IA-2βA by radioligand assay. The clinical features of the patients positive in different antibodies were analyzed. Results Thirty-five of the 401 T1DM patients were positive in IA-2βA with a positivity rate of 8.7%, significantly higher than that of the normal controls( 1.0 % ,2/100, P 〈 0.05 ). Out of the 35 cases with IA-2βA positivity, 16 (45.7%) were positive in IA-2A. Among the 401 T1DM patients, IA-2βA titer was not correlated with IA-2A titer ( r = 0.021, P = 0. 780). The IA-2βA positive rate of the age group of 0 - 9 years was 62.8%, significantly higher than that of the age group 〉 10 years ( 19.7 %, Χ^2 = 31.41, P 〈 0.001 ) ;and the IA-2A positive rate of the age group of 0 - 9 years was 20.0 %, significantly higher than that of the age group 〉 10 years (7.6 % ,Χ^2 =6.11 ,P 〈0.05). GADA was not significantly correlated with age. The age and onset age of the patients positive only in IA-2βA were 35.5 and 34.0 years respectively, both significantly higher than those of the patients positive only in IA-2A (24.2 and 21.6 years respectively, both P 〈 0.05). Conclusion Higher in child-onset T1DM, the prevalence of IA-2βA positivity decreases with age. IA-2βA is a practical parameter for identifying autoimmune diabetes.